Sphingosine-1-phosphate expression in human epiretinal membranes.

Area of Science:

• Ophthalmology
• Molecular Biology
• Cell Biology

Background:

• Abnormal posterior vitreous detachment (PVD) is implicated in epiretinal membrane (ERM) formation.
• The precise molecular mechanisms underlying ERM pathogenesis during PVD remain unclear.
• Sphingosine-1-phosphate (S1P) is a known mediator of mechanosensitive responses and may play a role in ERM development.

Purpose of the Study:

• To investigate the expression of S1P in human ERM specimens.
• To elucidate the role of S1P in the behavior of cultured human Muller glial cells.

Main Methods:

• Analysis of S1P expression in 24 human ERM specimens.
• Quantification of S1P+ cell density in relation to secondary ERM and ellipsoid zone (EZ) defects.
• In vitro experiments assessing the effect of S1P on human Muller glial cell migration, N-cadherin, and α-SMA expression.

Main Results:

• S1P expression was detected in 29.2% of ERM specimens.
• Significantly higher S1P+ cell density was observed in patients with secondary ERM (p=0.002) and EZ defects (p=0.036), indicative of abnormal PVD.
• S1P treatment enhanced Muller glial cell migration and increased N-cadherin and α-SMA expression.

Conclusions:

• S1P is present in human ERM and its expression correlates with indicators of abnormal PVD.
• S1P promotes Muller glial cell migration and expression of key proteins involved in cell adhesion and contractility.
• S1P is identified as a potential causative molecule in the development of ERM associated with abnormal PVD.